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Abstract. In the last years the neutrophil to lymphocyte ratio (NLR) has been examined in cardiovascular disorders and in
particular in coronary artery disease and acute myocardial infarction (AMI). Now we examined this parameter in subjects
with juvenile myocardial infarction at the initial stage and after 3 and 12 months. We enrolled 123 young subjects (112 men
and 11 women, mean age 39.4 ± 5.8 yrs) with AMI. The time interval between the AMI onset and the investigation was 13 ±
7 days. The mean value of NLR observed in young AMI subjects was significantly increased compared to normal controls
(N = 1.817 ± 0.711; young AMI subjects = 2.376 ± 0.873, p < 0.0001). NLR does not discriminate STEMI (2.427 ± 0.878)
and non STEMI (2.392 ± 0.868) or diabetics (2.604 ± 1.000) and non diabetics (2.324 ± 0.853), but it differentiates smokers
(2.276 ± 0.853) and non smokers (2.837 ± 1.072). NLR at the initial stage is not correlated with the number of cardiovascular
risk factors or with the extent of the coronary disease. In this study we found a significant decrease of neutrophil count at
3 and 12 months later AMI without any significant variation of lymphocyte and consequently we observed a decrease in
NLR at these two intervals of time in comparison with the initial stage. Despite some limitations present in this study, it is
interesting to underline that also in juvenile myocardial infarction this low-cost haematological marker may be considered
together with other inflammatory indicators.
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1. Introduction
Leukocyte (WBC) count is an independent predictor of acute myocardial infarction (AMI) and
elevated levels of WBCs seem to be correlated with a worse outcome, more complications and a
more extensive necrosis [3, 25, 26]. In subjects with coronary artery disease (CAD) WBC count
is correlated with smoking, arterial hypertension, diabetes mellitus, and apolipoprotein B [40]. As
it is known, leukocytes play a pivotal role in atherosclerosis development because their activation
is associated with impaired rheological properties, increased expression of adhesion molecules, and
overproduction of cytokines, proteolytic enzymes and reactive oxygen species (ROS) [25]. Leukocyte
subtypes are correlated with some cardiovascular risk factors: glucose level and arterial hypertension
were correlated with neutrophils, uric acid with neutrophils and monocytes, while smoking affected
all the subtypes [28]. An elevated neutrophil count correlates with higher risk of ischemic events
[26] and with AMI mortality [37]. The role of neutrophils in atherosclerosis is well known: primed
neutrophils infiltrating vascular wall release ROS, cytokines, myeloperoxidase, and elastase promoting
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plaque instability [12, 37]. The inflammatory status influences the neutrophil rheology and these cells,
become more rigid, may obstruct the smaller vessels and induce ischemia [37].
The relative lymphocyte count is related to survival in CAD subjects [38]. Lymphopenia has been
suggested as a prognostic indicator in ischemic heart disease [35] considering that, in subjects hospital-
ized for acute chest pain, a low relative lymphocyte count is a predictor of cardiovascular mortality and
late myocardial infarction [38]. Lymphopenia might be caused by the activation of the adrenal axis with
an increased cortisol and cathecolamine release [38], by a reduced lymphocyte production, a tissue
redistribution or an increased apoptosis, which is correlated with plaque instability in atherosclerotic
lesions [36]. The lymphocytes modulate the inflammatory response and T lymphocytes, producing
interferon , seem to regulate the smooth muscle cell proliferation into the vascular wall [23].
In the last decade the neutrophil to lymphocyte ratio (NLR) has been investigated in cardiovascular
disorders and it has been suggested as a prognostic factor in CAD [19]. NLR is negatively correlated
with the myocardial perfusion, as demonstrated in subjects with known or suspected CAD underwent a
cardiac positron emission tomography [48], and significantly correlated with the CAD severity [2]. In
subjects with stable chronic CAD, NLR is an independent predictor of cardiac death, in most cases due
to AMI [39]. A recent meta-analysis showed that NLR level is a predictor of all-cause mortality and of
major adverse cardiac events (MACE) in subjects undergoing angiography or cardiac revascularization,
mainly after AMI [47]. Cho et al. have demonstrated that subjects with high NLR had a worse clinical
outcome and higher mortality rates at 1 month and 6 months after percutaneous coronary intervention
(PCI) compared to those with a low NLR [13]. In STEMI subjects Nunez et al. observed an elevated
WBC count at the time of hospitalization, that decreased after 12–24 hours, an increased neutrophil
count at 12–24 hours after the admission, with a simultaneous reduction in lymphocyte count; therefore
the maximum level of NLR has been found at 12 to 24 hours and it has been correlated with mortality
increase [35]. An increasing rate of in-stent thrombosis, non-fatal MI and cardiovascular mortality has
been correlated with the NLR increase [27], as well as the frequency of ventricular tachyarrytmias
is associated with higher levels of NLR [20], which is considered a predictor of in-hospital and of
12-months MACEs and deaths after STEMI [22]. Sen et al. have studied STEMI subjects undergoing
primary PCI observing that an increased NLR is correlated with a more frequent coronary no-reflow
event [43]. Also other authors [27, 41, 45] found a higher prevalence of no-reflow after PCI in subjects
with increased NLR.
In non-STEMI subjects, higher NLR has been associated with a greater prevalence of atrial fibrillation
and heart failure, a lower left ventricular ejection fraction and grater rates of coronary artery bypass
grafting [5]. The average NLR results the best predictor of short- and long-term survival compared to
other leukocyte parameters, such as neutrophil or lymphocyte count [5], probably because this ratio is
less altered by other conditions, such as dehydration or over-hydration [4]. Lee et al. have demonstrated
that the NLR value at the admission is an independent predictor of 1-year reinfarction and mortality
in diabetic subjects with AMI [29].
Considering that up to now there are no literature data regarding the evaluation of the NLR in juvenile
myocardial infarction and also that NLR is an easily measurable laboratory parameter, the aim of our
study was to examine the NLR in subjects with juvenile AMI at the initial stage and after 3 and 12
months later. This study is a part of our scientific project identified as “Sicilian Study on Juvenile
Myocardial Infarction”.
2. Subjects and methods
In this study we examined 123 young subjects (112 men and 11 women) with recent acute myocardial
infarction, aged <46 years; the mean age was 39.4 ± 5.8 yrs. The time interval between AMI onset
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and the investigation was 13 ± 7 days. The diagnosis of myocardial infarction was made on the basis
of clinical picture, electrocardiography, blood testing (creatine kinase, troponin and myoglobin) and
ecocardiography.
In each subject we examined the presence of the principal cardiovascular risk factors, including
current smoking habits, family hystory of CAD, hypercholesterolemia, arterial hypertension, and
diabetes mellitus. Family hystory consisted in any first-grade relative with clinical manifestation of
CAD at age <55 yrs. Hypercholesterolemia was determined as a total cholesterol level >220 mg/dl
and/or the us of lipid lowering drugs. The diagnosis of arterial hypertension was based on blood
pressure measurements taken on two separate occasions with the patient in a seated position after
15 minutes of rest. The mean values of these measurements were considered. Arterial hypertension
was defined as a systolic blood pressure >140 mmHg and/or a diastolic blood pressure >90 mmHg
and/or the use of anti-hypertensive drugs. Diabetes mellitus was defined as a fasting blood glucose
level >126 mg/dl during the initial stage (13 ± 7 days after the AMI onset); otherwise diabetes was
suspected on the basis of the use of hypoglicemic agents. According to the number of cardiovascular
risk factors, the young AMI subjects were subdivided into 3 groups: 39 of them had 0 to 1 risk factor,
41 had 2 risk factors and 43 had 3 to 5 risk factors. 92 subjects had STEMI and 31 had non-STEMI.
In each subject the ejection fraction (EF) was evaluated by echocardiography at the time of the
admission. The mean EF in the whole group of AMI subjects was 54.63 ± 7.28%. There was no
significant difference in EF between STEMI (54.05 ± 7.68) and non-STEMI (56.14 ± 6.00) subjects.
Coronary angiography was performed only in 105 young AMI subjects. In the other cases the subject
declined his consent or the angiographic evaluation was not carried out because of the long distance
between the hospital in which the AMI was diagnosed and the angiographic unit of the universitary
center. The 105 subjects in which coronary angiography was effected were subdivided into 3 groups on
the basis of the extent of coronary lesions: 23 subjects did not show any significant coronary stenosis,
47 had a single-vessel disease (defined as a stenosis >70% in one coronary artery), and 35 had a
multi-vessel disease that is a stenosis >70% in at least 2 coronary vessels. No subject had previous
manifestations of coronary artery disease or other comorbidities.
83 young subjects with AMI were also examined at 3 months while only 66 were examined at 12
months.
The study was approved by the Ethical Committee. Blood samples were collected by venous puncture
from the antecubital vein and immediatly transferred to glass tube anticoagulated with EDTA-k3. White
blood cell, neutrophil and lymphocyte counts were obtained using an automated blood cell counter
while the neutrophil/lymphocyte ratio was calculated.
The same parameter was evaluated in a control group including 116 subjects (87 men and 29 women,
mean age 30.16 ± 7.03 yrs) without any sign of acute or chronic vascular diseases (history, physical
examination, laboratory and instrumental test); 81 of these subjects were non smokers, while 35 were
smokers.
3. Statistical analysis
Data were expressed as means ± s.d. The statistical difference between STEMI and non-STEMI,
diabetics and non-diabetics, and smokers and non-smokers was evaluated according to the Student t
test for unpaired data. The difference between the groups of AMI subjects subdivided according to the
number of cardiovascular risk factors and to the number of stenosed coronary vessels was explored
using the one-way analysis variance (ANOVA) model while for frequencies we employed the Fisher
exact test. The correlation between EF and NLR was examined using the linear regression; the same
statistical analysis was effected for the study of the correlation between age and NLR. The difference
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among the NLR value at the initial stage of AMI and at 3 and 12 months later was examined employing
the Student t test for paired data.
4. Results
First of all it must be underlined that the mean value of NLR found in young AMI subjects is
increased in comparison with that observed in the control group (N = 1.817 ± 0.711; young AMI
subjects = 2.376 ± 0.873, p < 0.0001). Examining the possible difference between men and women, we
found that NLR value was elevated in young AMI males in comparison with healthy men (p < 0.001);
no difference was noted between healthy women and young AMI females, as well as between young
AMI men and women.
At the initial stage no significant difference in NLR was observed between STEMI (NLR
2.427 ± 0.878) and non-STEMI (NLR 2.392 ± 0.868) as well as no difference was found between
diabetics (n = 17; NLR 2.604 ± 1.000) and nondiabetics (n = 107; NLR 2.324 ± 0.853). A significant
difference (p < 0.01) was observed instead between smokers (n = 101; NLR 2.276 ± 0.795) and non
smokers (n = 22; NLR 2.837 ± 1.072).
Subdividing the young AMI subjects according to the number of cardiovascular risk factors no
difference was observed among the 3 groups regarding the NLR (Table 1). Similarly, subdividing the
young AMI subjects according to the number of stenosed coronary vessels there was no difference
among the 3 groups (Table 1).
Subsequently we subdivided the whole group of AMI subjects into two subgroups according to the
median value (2.197) of NLR: low NLR and high NLR. In these 2 subgroups no statistical difference
regarding the main cardiovascular risk factors (Table 2) or the involved coronary vessels (Table 2) was
observed.
No correlation was found between age and NLR in the entire group of young AMI subjects
(r = –0.061) and in normal controls (r = – 0.057). There was no correlation between EF and NLR in
the whole group (r = –0.021) nor in the subgroups of STEMI (r = 0.032) and non-STEMI (r = –0.186)
subjects.
In the young AMI subjects we noted a significant decrease of the NLR at 3 months (Table 3) and at
12 months (Table 3) in comparison with the initial stage.
Table 1
Means ± S.D. of neutrophil count, lymphocyte count and NLR in AMI patients subdivided according to the number of risk
factors (A) or to the number of stenosed coronary vessels (B)
A 0–1 risk factor 2 risk factors >2 risk factors F
(n = 39) (n = 41) (n = 43)
Neutrophil count (N/mmc) 5423 ± 1895 5427 ± 1442 5642 ± 1817 0.22
Lymphocyte count (N/mmc) 2352 ± 680 2419 ± 575 2547 ± 675 0.98
NLR 2.453 ± 1.025 2.340 ± 0.718 2.340 ± 0.875 0.22
B No coronary lesions 1 stenosed vessel 2–3 stenosed vessels F
(n = 23) (n = 47) (n = 35)
Neutrophil count (N/mmc) 5710 ± 2048 5410 ± 1611 5871 ± 1530 0.78
Lymphocyte count (N/mmc) 2412 ± 590 2431 ± 697 2477 ± 619 0.08
NLR 2.485 ± 0.991 2.366 ± 0.814 2.485 ± 0.848 0.25
NLR = neutrophil/lymphocyte ratio.
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Table 2
Distribution of risk factors (A) and stenosed coronary vessels (B) in AMI patients subdivided according to NLR
A Low NLR (n = 62) High NLR (n = 61)
0–1 risk factor 18 (29%) 21 (34,4%)
2 risk factors 22 (35,5%) 19 (31,2%)
>2 risk factors 22 (35,5%) 21 (34,4%)
B Low NLR (n = 50) High NLR (n = 55)
No coronary lesions 11 (22%) 12 (21,8%)
1 stenosed vessel 24 (48%) 23 (41,8%)
2–3 stenosed vessels 15 (30%) 20 (36,4%)
Table 3
Means ± S.D. of neutrophil count, lymphocyte count and NLR in AMI patients at baseline and after three months (A), at
baseline and after 1 year (B)
A (n = 83) Baseline After 3 months
Neutrophil count (N/mmc) 5502 ± 1681 4745 ± 1668∗∗∗
Lymphocyte count (N/mmc) 2460 ± 676 2404 ± 595
NLR 2.363 ± 0.833 2.038 ± 0.701∗∗∗
B (n = 66) Baseline After 1 year
Neutrophil count (N/mmc) 5550 ± 1892 4814 ± 1725∗∗
Lymphocyte count (N/mmc) 2459 ± 689 2397 ± 561
NLR 2.358 ± 0.822 2.113 ± 0.932∗
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 vs Baseline (Student’s ‘t’ test for unpaired data).
5. Conclusive considerations
In our opinion the evaluation of the NLR reflects especially the systemic inflammatory response to
the infarcted myocardium. This assumption is confirmed by the fact that in adult AMI subjects some
authors [1, 27] have described a significant and positive correlation between hs-CRP and NLR; the
same positive correlation was also observed in a healthy US cohort [44]. Unfortunately, we have no
data regarding the relationship between NLR and CRP in these young AMI subjects.
In this group of young AMI subjects the NLR could not be considered a prognostic indicator for
the subsequent mortality or a marker of early risk stratification, but only an useful index to evaluate
together with other parameters, such as haemorheological determinants, plasma markers of platelet
and neutrophil activation, oxidative stress, elastase and protein oxidation (previously examined by our
group in juvenile myocardial infarction) [7–11, 30–33].
As it is known, the NLR reflects the balance between two different pathways considering that the
neutrophils are responsible for the active and non specific inflammatory response while the lymphocytes
are involved in the regulation of the immune system [5].
Our data show that this haematological index does not discriminate STEMI and non-STEMI subjects
as well as diabetics and nondiabetics. Regarding this last aspect, the literature data seem to be contrast-
ing; in fact, while some authors found a difference in NLR in relation to the diabetic disease [5, 29,
35], others did not point out this trend [13, 22, 24, 27, 43]. In our small survey this ratio differentiates
smokers and non smokers and this datum seems to agree with the findings of several authors [5, 13,
22, 35], but it is different from which observed by others [24, 27, 43].
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The results found in this study show that the NLR is not correlated to the number of cardiovascular
risk factors nor to the extent of coronary disease.
Our findings in any case are not comparable because, up to now, there are no data concerning the
behaviour of this parameter in juvenile myocardial infarction.
As it is known, in young adults AMI has a low incidence that varies between 2% and 10% according to
different surveys [14, 15, 17, 34, 49]. In the last years many papers have regarded the acute coronary syn-
dromes [18, 42] and the myocardial infarction in young patients [6, 21] although in these reports the age
considered has been respectively of 35 years [42], of 40 years [6, 18], and between 30 and 54 years [21].
Juvenile myocardial infarction has specific risk factors, clinical, angiographic, and prognostic char-
acteristics. Regarding the prognostic characteristics, the follow up carried by us till 18 months has
evidentiated that, among AMI subjects included in the subgroup of low NLR, 5 subjects developed a
new ischemic event, 3 subjects a heart failure and 3 subjects underwent revascularization, while among
those included in the subgroup of high NLR 8 subjects developed a new ischemic event, 3 subjects a
heart failure and 4 subjects underwent revascularization. Employing the Fisher exact test, the incidence
of each complication is not statistically different between these two subgroups (low and high NLR).
As previously noted by our group in two small groups of young AMI subjects [8, 33], in whom
we have examined the behaviour of the polymorphonuclear membrane fluidity and of the cytosolic
calcium content at baseline and after in vitro activation at the initial stage and after 12 months, also in
this study we found a significant decrease of neutrophil count at 3 and 12 months later AMI without
any significant variation of lymphocyte count, and consequently we observed a significant decrease in
NLR at these two intervals of time in comparison with the initial stage. This trend is probably due to
the reduction of the inflammatory status degree accompaning acute myocardial infarction.
This study shows some limitations. The first regards the number of young AMI subjects enrolled for
this research. The second is imputable to the fact that it is a retrospective study. The third limitation is
ascribable to the circumstance that the first determination of the NLR was effected during the initial
stage and not during the acute phase of the AMI. For this last reason we have not examined the
relationships between troponin or creatin kinase and NLR.
Despite these limitations, it is interesting to underline that this low-cost haematological marker may
be examined together with other inflammatory indicators in juvenile myocardial infarction.
NLR seems to give more information if compared with the total leukocyte count. In addition,
NLR seems to predict the no-reflow phenomenon in AMI subjects undergoing a primary coronary
revascularization, as described by other authors [27, 41, 43, 45], although we did not studied this
phenomenon.
NLR is influenced by diet plus physical exercise [47] and in fact in overweight adolescents a four
week diet and physical exercise intervention caused a significant reduction in the NLR. This finding
is important considering the long life expectancy of these young AMI subjects.
In conclusion, in this study, that is only an aspect of the Sicilian Study on Juvenile Myocardial Infarc-
tion, we have examined the behaviour of NLR showing that its increase is not influenced by the number
of cardiovascular risk factors nor by the extent of coronary involvement. We believe that this low-cost
haematological parameter is an usefull inflammatory marker accompanying myocardial infarction.
This research complies with the requirement for ethical publication in Clinical Hemorheology and
Microcirculation as published in Clin Hemorheol Microcirc. 2010;44(1):1–2.
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